Stem Cells USA & Regenerative Medicine Congress 2012
September 20 - 21, 2012
Cambridge MA , USA
Stem Cells USA & Regenerative Medicine Congress is the region's largest commercial stem cells conference
Most stem cell companies face two options - go bankrupt or find a partner with deep pockets. Despite there being hundreds of companies with promising technologies, most of them never pass Phase II trials due to lack of funding.
This year’s Stem Cells USA & Regenerative Medicine Congress will focus on strategies and business models to help you navigate this increasingly challenging marketplace, and to ensure your stem cell and regenerative medicine gets to market.
Most stem cell companies face two options - go bankrupt or find a partner with deep pockets. Despite there being hundreds of companies with promising technologies, most of them never pass Phase II trials due to lack of funding.
This year’s Stem Cells USA & Regenerative Medicine Congress will focus on strategies and business models to help you navigate this increasingly challenging marketplace, and to ensure your stem cell and regenerative medicine gets to market.
Related events
Stem Cells USA & Regenerative Medicine Congress September 30 - October 1, 2015
Stem Cells USA & Regenerative Medicine Congress September 30 - October 1, 2014
Stem Cells USA & Regenerative Medicine Congress September 30 - October 1, 2013
Stem Cells USA & Regenerative Medicine Congress September 20 - 21, 2012
Stem Cells USA & Regenerative Medicine Congress 2011 September 12 - 15, 2011
Stem Cells USA & Regenerative Medicine Congress 2010 September 13 - 15, 2010